| From: |
joya banerjee [ profile ] |
| Subject: |
GBCHealth Expert Connections Teleconference June 27: HIV Prevention Breakthroughs
|
| Sent: |
Jun 20th, 2012 - 11:07:48 |
|
| |
Hi Gabriel,
I'm so glad to see GYCA members participating in important technical
meetings such as this one. Treatment as Prevention and pre-exposure
prophylaxis (PrEP) are incredibly important tools for HIV prevention
that can be used in addition to existing efforts to halt & reverse HIV
incidence.
I wanted to flag an upcoming webinar/teleconference I organized in
case GYCA members would like to learn more about TasP and PrEP. Dr.
Bob Grant, the world's leading expert on PrEP from University of
California San Francisco will be speaking.
You will need to RSVP to receive dial-in details and a link to the live meeting.
http://gbchealth.org/event/144-expert_connections_teleconference_hiv_prevention_breakthroughs/
EVENT
Expert Connections Teleconference: HIV Prevention Breakthroughs
June 27, 2012
9:30 AM - 10:30 AM EST
Join GBCHealth for the first in a three-part Expert Connections
Teleconference series on HIV/AIDS, occurring before and after the
upcoming International AIDS Conference in Washington, DC.
Several recent breakthroughs in HIV prevention have given the
international community new hope that HIV infection rates can be
slowed dramatically. GBCHealth has assembled some of the best minds on
the topic for this teleconference.
Dr. Robert Grant from the Gladstone Institute of Virology and
Immunology, selected as one of TIME Magazine's 100 most influential
people of 2012, will explain how businesses that provide
antiretrovirals to their HIV positive employees can bring down
transmission by 96%, using treatment as prevention. He will also
discuss pre-exposure prophylaxis and his groundbreaking use of
antiretrovirals with high-risk HIV negative people to prevent
infection, proven to be up to 78% effective.
Recent studies have found medical male circumcision to be 76%
effective at preventing HIV, while also helping prevent certain
cancers and other STIs. Dr. Richard Wamai from Northeastern
University, who conducted one of the first randomized controlled
trials on male circumcision in Kenya, will discuss how business can
offer access to voluntary circumcision, a procedure that is
inexpensive, permanent, and can be done by a nurse where doctors are
scarce.
Finally, Unilevers Dr. Murray Coombs will discuss how to implement
effective HIV programs in the workplace, using an intervention that
engages men in family planning and health decision-making to increase
HIV testing and prevent mother-to-child transmission as an example.
Later in the year, Part 2 of this HIV series will focus on learning
and insights from the International AIDS Conference, and Part 3 will
explore the potential of business leadership on HIV policy.
Speakers Include:
- Joya Banerjee, Manager, Membership and Advisory Services, GBCHealth
- Dr. Robert Grant, Betty Jean and Hiro Ogawa Endowed Investigator,
Gladstone Institute of Virology and Immunology, University of
California-San Francisco
- Dr. Richard Wamai, Assistant Professor of African American Studies,
Northeastern University
- Dr. Murray Coombs, Occupational Health Advisor, Africa Regional
Group, Unilever (TBC)
Please contact Nisa Patel with any questions at npatel (at) gbchealth.org
or at 212-584-1613.
Best,
Joya
On Wed, Jun 20, 2012 at 10:24 AM, Gabriel, ADEYEMO wrote:
>
> Fellow GYCA Colleagues
>
>
> The concepts of antiretroviral-based Treatment as Prevention (TasP) and
> Pre-Exposure Prophylaxis (PrEP) gained formidable ground in 2011, both
> cited in numerous 2011 Top 10 lists of clinical development in HIV
> medicine. In addition, PrEP has recently been a topic of heated debate as
> regulatory bodies most notably the US Food and Drug Administration (FDA)
> entertain approving expanded indications for existing antiretroviral
> drugs for HIV prevention.
>
>
>
> Last week (June 11th and 12th) 2012, the International Association of
> Physicians in AIDS Care (IAPAC), in partnership with the British HIV
> Association (BHIVA), hosted a two-day; Controlling the HIV Epidemic with
> Antiretrovirals summit with a goal of providing a venue for the
> presentation of data related to and discussion about the practical aspects
> of TasP and PrEP implementation in a variety of clinical settings.
>
>
>
> GYCA of course had good representatives at this meeting. Edmond Atindaana (
> atindaana (at) live.com) from Ghana and Gabriel Adeyemo, West Africa RFP both
> participate in this meeting in a process to learning more about prevention
> sciences and also advocate for young peoples inclusion into Vaccine
> development components on HIV/AIDS/STIs.
>
>
> For both of us, it was another high level meeting to discuss pure research
> and vaccine development in the HIV field. Listening to great researchers
> and authors in the public health field was wonderful, getting to speak our
> mind as a young person at various intervals and mincing with world renowned
> scientist was also interesting. One major question that struck our mind was
> "If PrEP and TasP are going to become realities therefore, implementation
> must be phased and not before substantial health system strengthening. Can
> the fact that treatment is now prevention achieve what Universal Access
> could not"?
>
>
> All presentation made at this meeting are available on the IAPACs website;
> http://www.iapac.org/tasp_prep/index.html And a consensus points were
> reached, which will be featured in a statement to be released at the XIX
> International AIDS Conference in Washington, DC, USA.
>
>
> Send email to iapac (at) iapac.org with subject "Consensus Statement" to request
> a copy of the Consensus Statement.
>
>
> Among lessons learnt in this meeting personally was;
>
> - Public health and human rights imperatives in a combination
> prevention strategy
>
> - The role of ARVs in prevention; TasP and PrEP
>
> - Challenges that research and implementation often face,
>
> - Intensifying and scale-up ART for those with CD4
>
> - - - - - - - - - - - - - - - - - - - - - - -
>
> -www.gyca.org-
>
> E-Group Webpage (manage your settings, see message archives, etc): http://groups.takingitglobal.org/gyca
> Send a message: gyca (at) groups.takingitglobal.org
> Subscribe: gyca-subscribe (at) groups.takingitglobal.org
> Unsubscribe: gyca-unsubscribe (at) groups.takingitglobal.org
>
>
> -------------------------------------------
>
> * Powered By TIG Groups http://groups.takingitglobal.org/
> * Group Archives: http://groups.takingitglobal.org/GYCA/messages/
> * To unsubscribe, email GYCA-unsubscribe (at) groups.takingitglobal.org
> * My subscription settings, GYCA-settings (at) groups.takingitglobal.org
|
|
Message
back to messages
